Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Astimex Pharma Aktiebolag
AB
Active
Org 5566213780
Isafjordsgatan 36, 164 40
Kista
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2002
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Astimex Pharma Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
21M
42M
63M
84M
38M
2021
40M
2022
53M
2023
73M
2024
56M
2025
EBITDA
SEK millions
0M
9M
18M
28M
37M
13M
2021
11M
2022
19M
2023
32M
2024
22M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
38 392
39 928
53 442
73 186
56 184
Staff expenses
—
—
—
−4 910
−5 903
EBITDA
12 781
11 323
18 646
31 910
21 780
Depreciation & amort.
−122
−62
−46
−13
−5
EBIT
12 659
11 261
18 600
31 897
21 775
Net financials
—
—
660
1 407
1 045
Profit before tax
9 492
8 373
14 335
33 304
22 820
Tax
−2 070
−1 841
−3 093
−7 142
−4 826
Net profit
7 422
6 532
11 242
26 162
17 994
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
41 064
52 925
65 239
52 579
70 380
Equity
30 812
35 343
42 585
26 747
44 742
Long-term debt
0
0
0
—
—
Short-term debt
3 266
7 708
7 854
11 032
10 838
Total debt
3 266
7 708
7 854
11 032
10 838
Financial ratios
5-year trend
EBITDA margin
38.8%
This company
15.8%
Market median
+146% vs market
2021
2025
Equity ratio
63.6%
This company
38.2%
Market median
+66% vs market
2021
2025
Return on equity
40.2%
This company
18.4%
Market median
+118% vs market
2021
2025
Net profit margin
32.0%
This company
8.1%
Market median
+295% vs market
2021
2025
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2021
2025
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
View
PDF
More on Astimex Pharma Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
